Published in Mol Neurodegener on June 18, 2012
JNK-interacting protein 3 mediates the retrograde transport of activated c-Jun N-terminal kinase and lysosomes. PLoS Genet (2013) 1.05
The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol Neurodegener (2014) 0.85
Axonal transport plays a crucial role in mediating the axon-protective effects of NmNAT. Neurobiol Dis (2014) 0.84
Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's Disease. Pharmaceuticals (Basel) (2012) 0.81
Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus. PLoS One (2013) 0.81
Axonal transport rate decreased at the onset of optic neuritis in EAE mice. Neuroimage (2014) 0.77
The preventive effect of oxytocin to Cisplatin-induced neurotoxicity: an experimental rat model. Biomed Res Int (2015) 0.77
Sod1 gene ablation in adult mice leads to physiological changes at the neuromuscular junction similar to changes that occur in old wild-type mice. Free Radic Biol Med (2015) 0.77
Kif1B Interacts with KBP to Promote Axon Elongation by Localizing a Microtubule Regulator to Growth Cones. J Neurosci (2016) 0.77
Regulation of mitochondria-dynactin interaction and mitochondrial retrograde transport in axons. Elife (2017) 0.77
Decreased Energy Capacity and Increased Autophagic Activity in Optic Nerve Axons With Defective Anterograde Transport. Invest Ophthalmol Vis Sci (2015) 0.76
Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport. Mol Neurodegener (2017) 0.75
A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease. Front Cell Neurosci (2016) 0.75
Nanoparticle-assisted optical tethering of endosomes reveals the cooperative function of dyneins in retrograde axonal transport. Sci Rep (2015) 0.75
Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum. Int J Mol Sci (2014) 0.75
ROS homeostasis as a prerequisite for the accomplishment of plant cytokinesis. Protoplasma (2016) 0.75
Culturing hippocampal neurons. Nat Protoc (2007) 8.34
Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66
Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol (2002) 6.68
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature (2009) 6.17
Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem (2008) 5.94
Kinesin superfamily motor proteins and intracellular transport. Nat Rev Mol Cell Biol (2009) 5.61
Kinesin hydrolyses one ATP per 8-nm step. Nature (1997) 4.57
Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J Cell Biol (2006) 4.28
The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility. Cell (2009) 4.26
The role of inflammation in CNS injury and disease. Br J Pharmacol (2006) 3.96
Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry (1998) 3.90
The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron (2005) 3.71
Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell (2001) 3.49
Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron (2009) 3.49
Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci (2010) 3.22
Coupling of kinesin steps to ATP hydrolysis. Nature (1997) 3.02
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med (2011) 3.00
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol (2010) 2.43
Oxidative stress and neurotoxicity. Chem Res Toxicol (2007) 2.12
Retrograde axonal transport: pathways to cell death? Trends Neurosci (2010) 2.06
Developments in neuronal cell culture. Nature (1988) 1.90
Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci U S A (2007) 1.76
Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol (2003) 1.73
The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci (2006) 1.68
Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A (2010) 1.66
Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons. J Neurosci (2010) 1.62
Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J Neurosci (2008) 1.54
Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology (2004) 1.51
Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res Mol Brain Res (2005) 1.45
Kinesin assembly and movement in cells. Annu Rev Biophys (2011) 1.32
Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin. J Neurosci (2008) 1.26
Anterograde axonal transport, transcytosis, and recycling of neurotrophic factors: the concept of trophic currencies in neural networks. Mol Neurobiol (2002) 1.22
Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur J Neurosci (2001) 1.18
A signal sequence is sufficient for green fluorescent protein to be routed to regulated secretory granules. Endocrinology (2001) 1.17
Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector. Hum Gene Ther (2004) 1.16
Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochem Res (1997) 1.02
Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide. J Neurosci (2005) 1.00
Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol (2005) 0.96
Oxidative stress and altered mitochondrial function in neurodegenerative diseases: lessons from mouse models. CNS Neurol Disord Drug Targets (2010) 0.92
Hydrogen peroxide induces neurite degeneration: Prevention by tocotrienols. Free Radic Res (2011) 0.90
Mechanisms of sodium azide-induced changes in intracellular calcium concentration in rat primary cortical neurons. Neurotoxicology (2007) 0.86
A perspective on neuronal cell death signaling and neurodegeneration. Mol Neurobiol (2010) 0.86
Increase in core body temperature of Alzheimer's disease patients as a possible indicator of chronic neuroinflammation: a meta-analysis. Gerontology (2006) 0.82
Mechanisms of neurodegenerative diseases: insights from live cell imaging. J Neurosci Res (2008) 0.79
Analysis of mitochondrial DNA in microfluidic systems. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.78
Culturing hippocampal neurons. Nat Protoc (2007) 8.34
Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res (2005) 2.39
A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J Neurosci (2007) 1.97
Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat Neurosci (2009) 1.95
"Undiagnosing" multiple sclerosis: the challenge of misdiagnosis in MS. Neurology (2012) 1.94
Posttranslational modifications of tubulin and the polarized transport of kinesin-1 in neurons. Mol Biol Cell (2009) 1.93
Two distinct mechanisms target membrane proteins to the axonal surface. Neuron (2003) 1.82
Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci U S A (2007) 1.76
Regulation of axonal extension and growth cone motility by calmodulin-dependent protein kinase I. J Neurosci (2004) 1.57
Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology (2014) 1.54
Automatic summarization of changes in biological image sequences using algorithmic information theory. IEEE Trans Pattern Anal Mach Intell (2009) 1.51
Transient receptor potential canonical 5 channels activate Ca2+/calmodulin kinase Igamma to promote axon formation in hippocampal neurons. J Neurosci (2009) 1.48
Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction. Somatosens Mot Res (2008) 1.42
Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis. Curr Neurol Neurosci Rep (2009) 1.37
Axonal transport analysis using Multitemporal Association Tracking. Int J Comput Biol Drug Des (2012) 1.34
General considerations for live imaging of developing hippocampal neurons in culture. Cold Spring Harb Protoc (2012) 1.34
Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro. J Pharm Pharmacol (2005) 1.33
Short-term high-resolution imaging of developing hippocampal neurons in culture. Cold Spring Harb Protoc (2012) 1.17
Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis. J Neuroimmunol (2009) 1.17
Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler (2011) 1.16
Long-term time-lapse imaging of developing hippocampal neurons in culture. Cold Spring Harb Protoc (2012) 1.16
A novel sorting motif in the glutamate transporter excitatory amino acid transporter 3 directs its targeting in Madin-Darby canine kidney cells and hippocampal neurons. J Neurosci (2002) 1.09
The translocation selectivity of the kinesins that mediate neuronal organelle transport. Traffic (2012) 1.06
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects. Eur J Immunol (2013) 1.04
Falls requiring medical attention among veterans with multiple sclerosis: a cohort study. J Rehabil Res Dev (2011) 1.02
Activation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons. Eur J Neurosci (2011) 1.02
Automated semantic analysis of changes in image sequences of neurons in culture. IEEE Trans Biomed Eng (2006) 1.02
Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. CNS Drugs (2002) 1.01
The radiologically isolated syndrome: look (again) before you treat. Curr Neurol Neurosci Rep (2011) 1.01
Immunotherapy and multiple sclerosis: The devil is in the details. Neurology (2010) 0.98
Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PLoS One (2013) 0.97
A novel split kinesin assay identifies motor proteins that interact with distinct vesicle populations. J Cell Biol (2012) 0.97
Selective microtubule-based transport of dendritic membrane proteins arises in concert with axon specification. J Neurosci (2014) 0.96
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients. Mult Scler (2013) 0.95
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis: eight-year follow-up. Arch Neurol (2010) 0.94
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis (2014) 0.91
Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis. Eur J Neurosci (2012) 0.91
Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. J Immunol (2003) 0.90
Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis. J Neuroimmunol (2011) 0.90
Fingolimod and multiple sclerosis: four cautionary tales. Neurology (2012) 0.90
Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol (2010) 0.89
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures. Mult Scler Int (2013) 0.88
Automated kymograph analysis for profiling axonal transport of secretory granules. Med Image Anal (2010) 0.88
Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths. J Altern Complement Med (2004) 0.87
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences. Neurology (2013) 0.87
Novel method for measurement of fatigue in multiple sclerosis: Real-Time Digital Fatigue Score. J Rehabil Res Dev (2010) 0.87
Mitochondrial calcium and its regulation in neurodegeneration induced by oxidative stress. Eur J Neurosci (2011) 0.87
Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial. Neurology (2012) 0.84
Neuroregenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neuropathies. Neurol Res (2004) 0.83
People with multiple sclerosis use many fall prevention strategies but still fall frequently. Arch Phys Med Rehabil (2013) 0.83
Complementary and alternative medicine: is there a role in multiple sclerosis? Curr Neurol Neurosci Rep (2006) 0.83
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis. Front Physiol (2013) 0.83
Autoantibodies and Sjogren's Syndrome in multiple sclerosis, a reappraisal. PLoS One (2013) 0.81
Perceived stress in multiple sclerosis: the potential role of mindfulness in health and well-being. J Evid Based Complementary Altern Med (2014) 0.81
New disease-modifying therapies and new challenges for MS. Curr Neurol Neurosci Rep (2012) 0.79
Recent developments in multiple sclerosis therapeutics. BMC Med (2009) 0.79
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges. Front Physiol (2012) 0.78
Frequency-modulation (FM) technology as a method for improving speech perception in noise for individuals with multiple sclerosis. J Am Acad Audiol (2006) 0.78
Nonmyelin-specific T cells accelerate development of central nervous system APC and increase susceptibility to experimental autoimmune encephalomyelitis. J Immunol (2003) 0.77
A randomized pilot study of naturopathic medicine in multiple sclerosis. J Altern Complement Med (2008) 0.77
Postmarketing adverse drug reactions: A duty to report? Neurol Clin Pract (2013) 0.77
Remyelination and multiple sclerosis: therapeutic approaches and challenges. Curr Neurol Neurosci Rep (2014) 0.77
Focal increases of axoplasmic Ca2+, aggregation of sodium-calcium exchanger, N-type Ca2+ channel, and actin define the sites of spheroids in axons undergoing oxidative stress. J Neurosci (2012) 0.77
The radiologically isolated syndrome: is it very early multiple sclerosis? Neurology (2008) 0.76
Putting on the RITz. Sci STKE (2007) 0.76
Reply: To PMID 19798640. Ann Neurol (2010) 0.75
The radiologically isolated syndrome revisited: when is it presymptomatic multiple sclerosis? Neurology (2011) 0.75
Interruption of natalizumab therapy for multiple sclerosis: what are the risks? Neurology (2011) 0.75
Oral disease-modifying therapies for multiple sclerosis: are we there yet? Curr Neurol Neurosci Rep (2010) 0.75
New oral disease-modifying therapies for multiple sclerosis. F1000 Med Rep (2009) 0.75
Depression is a treatable cause of suffering among multiple sclerosis patients and can result in suicide. Neurology (2002) 0.75
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. Curr Neurol Neurosci Rep (2008) 0.75
The clathrin adaptor complex responsible for somatodendritic protein sorting. Neuron (2012) 0.75
The use of flow cytometry to assess a novel drug efficacy in multiple sclerosis. Metab Brain Dis (2014) 0.75
Anti-NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association? Clin Auton Res (2012) 0.75
Does interferon beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis? J Neurosci Nurs (2014) 0.75
MS and bone marrow transplant: Not for most patients. Neurology (2017) 0.75
Early Fever As a Predictor of Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury. J Head Trauma Rehabil (2017) 0.75